Horizon Therapeutics has a total of 1331 patents globally, out of which 582 have been granted. Of these 1331 patents, more than 47% patents are active. The United States of America is where Horizon Therapeutics has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Horizon Therapeutics.
Horizon Therapeutics was founded in the year 2005. The Company is a biotechnology company. The Company focuses on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. As of March 2023, the market cap of Horizon Therapeutics is $25.14 Billion.
Do read about some of the most popular patents of Horizon Therapeutics which have been covered by us in this article and also you can find Horizon Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Horizon Therapeutics patent portfolio.
How many patents does the founder and the CEO of Horizon Therapeutics have?
The founder George F. Tidmarsh has 2 patents and CEO Timothy P Walbert has 0 patent.
How many patents does Horizon Therapeutics have?
Horizon Therapeutics has a total of 1331 patents globally. These patents belong to 220 unique patent families. Out of 1331 patents, 634 patents are active.
How Many Patents did Horizon Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Horizon Therapeutics Applications Filed||Horizon Therapeutics Patents Granted|
How many Horizon Therapeutics patents are Alive/Dead?
How Many Patents did Horizon Therapeutics File in Different Countries?
Countries in which Horizon Therapeutics Filed Patents
|United States Of America||270|
|Hong Kong (S.A.R.)||47|
|Gulf Cooperation Council||3|
Where are Research Centres of Horizon Therapeutics Patents Located?
10 Best Horizon Therapeutics Patents
US20030129186A1 is the most popular patent in the Horizon Therapeutics portfolio. It has received 490 citations so far from companies like Medtronic, Angiochem and Genentech.
Below is the list of 10 most cited patents of Horizon Therapeutics:
|Publication Number||Citation Count|
How many inventions of other companies were rejected due to Horizon Therapeutics patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Horizon Therapeutics invention. They couldn’t because Horizon Therapeutics had protected those before them.
Examiners at the USPTO referred 54 Horizon Therapeutics patents in 317 rejections (35 USC § 102 or 35 USC § 103 types).
The top citing companies in the Horizon Therapeutics patent portfolio are Citibank Na, Horizon Orphan and Horizon Medicines.
List of the Companies whose Patents were rejected citing Horizon Therapeutics –
|Company||Number of Patent Applications that faced Rejection Citing Horizon Therapeutics Patents||Number of Rejections (102 & 103)|
|National Institutes Of Health||4||14|
Count of 102 and 103 Type Rejections based on Horizon Therapeutics Patents
Top Horizon Therapeutics Patents used in Rejecting Most Patent Applications
|Patent Number||Count of Rejected Applications|
What Percentage of Horizon Therapeutics US Patent Applications were Granted?
Horizon Therapeutics (Excluding its subsidiaries) has filed 101 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 53 have been granted leading to a grant rate of 57.61%.
Below are the key stats of Horizon Therapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Horizon Therapeutics?
|Law Firm||Total Applications||Success Rate|
|Global Patent Group||36||63.89%|
|Global Patent Group||33||45.45%|
|Cooley Llp Horizon Therapeutics||11||85.71%|
|Foley & Lardner||6||20.00%|
|Kilpatrick Townsend & Stockton||3||0.00%|
|David J Brezner||1||0%|